TABLE 6.
Role of CLAs against cancer.
Year | Probiotic strain | Cancer type | Study subject (cell lines/test animals) | Outcome | References |
---|---|---|---|---|---|
2006 | Bifidobacterium breve | Colon cancer | HT-29, CaCo-2 | Suppression of cancer cell proliferation | Coakley et al. (2006) |
VSL-3 | Colon cancer | HT-29, CaCo-2 | Induction of apoptosis, upregulation of PPARγ expression | Ewaschuk et al. (2006) | |
2007 | Propionibacterium acnes | Colon cancer | SW480 | Concentration-dependent growth inhibition of cancer cells, suppression of cell proliferation | Rosberg-Cody et al. (2007) |
2009 | Bifidobacterium breve NCIMB 702258 | Colon cancer | SW480 | Suppression of growth of SW480 cells | Coakley et al. (2009) |
2016 | Pediococcus pentasaceus GS4 | Colon cancer | HCT-116 | Downregulation of NF-κB and p-Akt, induction of apoptosis, and inhibition of cell proliferation | Dubey et al. (2016) |
Bifidobacterium breve DPC6330 | Colon cancer | SW480 | Downregulation of Bcl-2 gene expression, suppression of cancer cell proliferation | Hennessy et al. (2016) | |
Lactobacillus plantarum | Breast cancer | MDB-MB-231 | Suppression of NF-κB pathway, degradation of proteasome of IқBα, upregulation of Bax gene, and release of Cyt-C from mitochondria | Kadirareddy et al. (2016) | |
2023 | Pediococcus pentasaceus GS4 | Colon cancer | HCT-116 | Reduced expression of COX-2 and 5-LOX, mitochondrial membrane depolarization, and increase in caspase 1p10 expression | Dubey et al. (2023) |